small amounts of soluble fiber (oats, chia if tolerated)
GLP-1 medications can be helpful for many patients, but they are not the right long-term answer for everyone
1.3 In vitro Tirzepatides effects In vivo and in vitro preclinical studies have demonstrated that co-administration of GIP and GLP1 promotes insulin sensitivity, leading to better blood glucose level control, more sustained reduction in food intake and consequently better WL compared to the infusion of a single agent (35, 41, 46), also exerts an additive effect on metabolism of cyclic adenosine monophosphate (cAMP), thus increasing its levels and consequently, potentiating insulin secretion glucose-dependent
Weight loss is known to impact your insulin sensitivity and resistance, both of which can affect your period, especially if you have PCOS
Over the past year, Novo Nordisk has achieved significant growth internationally with its GLP-1 class of drugs such as Ozempic (semaglutide) and Rybelsus (oral semaglutide), particularly in the North American market and its global operations